Results 221 to 230 of about 811,687 (352)

Real-World Data on the Efficacy and Safety of Osilodrostat in Patients with Cushing's Disease in Spain. [PDF]

J Clin Med
Araujo-Castro M, García-Centeno R, González L, Hanzu FA, Orois A, Camara R, García MDO, Echarri AI, Gracia Gimeno P, Pascual-Corrales E, Biagetti B, Cardona A, González Molero I, Simo-Servat A, Guerrero Pérez F, Villar-Taibo R, Bernabéu I, Fajardo-Montañana C, Novo-Rodríguez C, Tenorio Jimenéz C, Calatayud M, Moure Rodríguez MD, Cordido F, Castro A, Valero LM, Paja Fano M, Goi J, Aulinas A, Abellán P, Iglesias P, Soto-Moreno A.   +30 more
europepmc   +1 more source

Session 66 – Endocrinology—Clinical [PDF]

, 2006

openalex   +1 more source

N‐terminal pro‐brain natriuretic peptide and cardiorenal outcome in patients with anaemia in chronic kidney disease

ESC Heart Failure, Volume 12, Issue 2, Page 848-858, April 2025.
Abstract Aims Blood levels of N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) may be modified by low renal clearance and anaemia. The aim of this study was to investigate the impact of the blood NT‐proBNP level on cardiovascular and renal outcomes in patients with these two manifestations.
Hiroshi Nishi, Masaomi Nangaku, Tadashi Sofue, Tatsuo Kagimura, Ichiei Narita   +4 more
wiley   +1 more source

Myocardial inflammation is associated with impaired mitochondrial oxidative capacity in ischaemic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1246-1255, April 2025.
Abstract Aims Myocardial inflammation and impaired mitochondrial oxidative capacity are hallmarks of heart failure (HF) pathophysiology. The extent of myocardial inflammation in patients suffering from ischaemic cardiomyopathy (ICM) or dilated cardiomyopathy (DCM) and its association with mitochondrial energy metabolism are unknown.
Julius Borger, Elric Zweck, Constanze Moos, Patrick Horn, Fabian Voß, Heinz‐Peter Schultheiss, Jacob Eifer Møller, Udo Boeken, Hug Aubin, Artur Lichtenberg, Malte Kelm, Michael Roden, Amin Polzin, Ralf Westenfeld, Julia Szendroedi, Daniel Scheiber   +15 more
wiley   +1 more source

Correction: Prevalence, awareness, treatment, and control of prediabetes and diabetes mellitus in older adults: findings from Iranian STEPS surveys (2016 and 2021). [PDF]

BMC Public Health
Nikkhah A, Farzi Y, Azizpour Y, Rezaei N, Mirzad M, Shahrestanaki SK, Sharifi F, Akbarpour S, Tabatabaei-Malazy O, Payab M, Ebrahimpur M.   +10 more
europepmc   +1 more source

Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016.

European Journal of Endocrinology, 2018
A. McCormack, O. Dekkers, S. Petersenn, V. Popović, J. Trouillas, G. Raverot, P. Burman   +6 more
semanticscholar   +1 more source

Effects of sodium–glucose co‐transporter inhibitors on individual clinical endpoints and quality of life

ESC Heart Failure, Volume 12, Issue 2, Page 1271-1282, April 2025.
Effects of SGLTi on Individual Clinical Endpoints and Quality‐of‐Life: outcome from randomized data. Abstract Aims Sodium–glucose co‐transporter inhibitors (SGLTis) have cardiovascular protective effects. We aimed to assess the effects of SGLTis on individual hard clinical endpoints and quality of life (QoL) in patients with cardiovascular risk factors.
Jia Liao, Yang Chen, Zhiyu Ling, Helmut Pürerfellner, Martin Martinek, Michael Derndorfer, Johannes Niel, Ramin Ebrahimi, Matthias Heukäufer, Sarah Janschel, Davide Di Vece, Klaus Empen, Astrid Hummel, Bishwas Chamling, Piotr Futyma, Fahim Ebrahimi, Márcio G. Kiuchi, Shaowen Liu, Yuehui Yin, Alexandra Schratter, Willem‐Jan Acou, Philipp Sommer, Boris Schmidt, Julian K. R. Chun, Christian Meyer, Marcus Dörr, Christian Templin, Shaojie Chen   +27 more
wiley   +1 more source

Nephroendocrinology: When endocrinology meets nephrology [PDF]

, 2017
Edgar V. Lerma, Christian A. Koch
openalex   +1 more source

Klinefelter Syndrome: Integrating Genetics, Neuropsychology, and Endocrinology.

Endocrine reviews, 2018
C. Gravholt, Simon Chang, M. Wallentin, J. Fedder, P. Moore, A. Skakkebæk   +5 more
semanticscholar   +1 more source

Semaglutide normalizes increased cardiomyocyte calcium transients in a rat model of high fat diet‐induced obesity

ESC Heart Failure, Volume 12, Issue 2, Page 1386-1397, April 2025.
Sequeira et al. reveal how the glucagon‐like peptide‐1 receptor agonist (GLP‐1‐RA) semaglutide restores cardiomyocyte function in rats subjected to a high‐fat/high‐fructose diet (HFD). Employing fluorescence‐ and patch‐clamp technology in isolated cardiac myocytes, they demonstrate that semaglutide reverses HFD‐induced activation of L‐type calcium ...
Vasco Sequeira, Julia Theisen, Katharina J. Ermer, Marie Oertel, Anton Xu, David Weissman, Katharina Ecker, Jan Dudek, Martin Fassnacht, Alexander Nickel, Michael Kohlhaas, Christoph Maack, Ulrich Dischinger   +12 more
wiley   +1 more source